LUCINE
Financiado
LUCINE THE COMPREHENSIVE PERSONALIZED AND SAFE eHEALTH SOLUTION THAT ACCURATEL...
LUCINE THE COMPREHENSIVE PERSONALIZED AND SAFE eHEALTH SOLUTION THAT ACCURATELY MEASURES ANALIZES AND RELIEVES PAIN
LUCINE is a revolutionary, clinically validated, solution for chronic pain diagnosis and management. Chronic pain is a global pandemic that affects 100 million Europeans. The management of pain is not adapted to the needs of the p...
LUCINE is a revolutionary, clinically validated, solution for chronic pain diagnosis and management. Chronic pain is a global pandemic that affects 100 million Europeans. The management of pain is not adapted to the needs of the patients or the expectations of health professionals. When it becomes chronic, pain becomes an illness and has dramatic social, economic and public health impacts. Each year, approximately 1 in 5 Europeans are affected by chronic pain. Chronic pain adversely affects patient’s quality of life and can even limit a person’s movements, further interfering with daily activities. Health professionals lack the time and the tools to address a phenomenon as personal and subjective as pain. Still, chronic pain accounts for 22% of primary care physicians consults, with over a third of adult appointments involving a patient in chronic pain. The cost of pain at the European level can be estimated at € 441 billion. As a company, LUCINE is a leading innovator on pain diagnosis and management. LUCINE ́s customized mobile application is the first digital solution that can measure and analyse all facets of a patient’s pain, in 45 seconds. It utilises the smartphone’s camera and microphone to measure a patient’s pain levels through facial, postural, vocal and environmental recog¬nition. It provides an objective measurement of the patient’s pain level on a scale of 1 to 100.
Moreover, LUCINE is the first digital pharmacy that offers personalised immersive healthcare solutions to relieve pain. Yet it relies on existing devices (smartphone, VR sets), by offering a variety of care adapted to the environment, pain levels and patient’s profile.
Based on the data collected our system adapts the treatment to the tastes, attitudes, habits, and culture of the user. LUCINE’s products are targeting a large global market of € >350 billion represented by the over 1.5 billion individuals across the world who sufferfrom this type of pain.
ver más
Duración del proyecto: 4 meses
Fecha Inicio: 2019-05-06
Fecha Fin: 2019-09-30
Fecha Fin: 2019-09-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-09-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
LUCINE SAS
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
451.45K€ |
Participante